Kemin Industries Strengthens Digestive Health Innovations with New Acquisition of Bactana

Kemin Industries Strengthens Digestive Health Innovations with Bactana Acquisition

Kemin Industries, a leading global ingredient manufacturer, has recently made waves in the health sector with its acquisition of Bactana, a company that specializes in pioneering advances in intestinal health and fermentation technology. This strategic move is set to reinforce Kemin's commitment to scientific innovation in gut health, aligning perfectly with the company's long-term vision.

The announcement was made on May 12, 2025, from the company’s headquarters in Des Moines, Iowa. Kemin has a remarkable reputation for enhancing quality of life for a significant portion of the global population, and this latest acquisition is seen as a further enhancement of its capabilities. Founded in 2017 as a spinoff from Cornell University's McGovern Center, Bactana has become known for its cutting-edge research in this critically important field.

Building on Proven Expertise

As Kimberly Nelson, President of Kemin Nutrisurance, stated, the integration of Bactana into Kemin's existing framework is driven by a collective curiosity and dedication to devise innovative solutions that support metabolism, immune functions, and overall wellness. Nelson expressed confidence in combining Bactana's advanced research methodologies with Kemin's extensive expertise, which is expected to yield significant advancements in intestinal health.

The acquisition underscores Kemin Nutrisurance’s strategic initiative to advance research and expedite the development of solutions that can adapt to emerging technologies in gut health, thereby solidifying its position as an industry leader. This strategic investment demonstrates a clear focus on addressing the complexities of digestive health through a robust scientific foundation.

Enhanced Health Solutions

By leveraging its global resources and scientific acumen, Kemin plans to accelerate the development of Bactana's unique technologies and expand their applications worldwide. The tandem of Kemin's established experience and Bactana's innovative spirit holds tremendous potential for creating groundbreaking solutions that could elevate health and nutrition standards globally.

John Kallassy, CEO of Bactana Corp, expressed his gratitude to employees and stakeholders who have supported the company's mission. He emphasized that teaming up with Kemin is a profound way to further advance their technology and extend its global reach and impact. Bactana’s advancements in fermentation and gut health are truly at the forefront of a public health initiative aimed at enhancing well-being through scientific discovery.

About Kemin Industries

For over 60 years, Kemin Industries has made it its mission to sustainably transform the quality of life for people around the world. With over 500 specialized ingredients provided to various sectors, including human health, animal nutrition, aquaculture, and more, the company has established itself as a cornerstone of quality in the health sector.

Kemin has a proven track record of utilizing applied science to tackle industry challenges, offering effective product solutions to customers across more than 120 countries. The company, which has operations in 90 countries, prides itself on providing the highest quality, safe, and effective ingredients that meet the diverse needs of a growing global population.

With its private, family-owned structure and a workforce of over 3,500 employees worldwide, Kemin is set to continue leading the way in innovation, especially in fields as critical as intestinal health.

As Kemin Industries integrates Bactana into its larger framework, the future of health sciences looks promising, further driven by advancements in fermentation technology and gut health.